Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.16.8) and a new date (2025-07-20), replacing the previous revision (v2.16.6) and date (2025-07-08).
    Difference
    1%
    Check dated 2025-07-25T14:40:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-18T11:33:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page now includes a service alert regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, a date has been added, while a previous date has been removed.
    Difference
    4%
    Check dated 2025-07-11T07:22:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    4%
    Check dated 2025-07-04T04:04:21.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    3%
    Check dated 2025-06-19T19:52:00.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The date has been updated from May 29, 2025, to June 8, 2025.
    Difference
    0.6%
    Check dated 2025-06-12T15:38:48.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.